Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Placebo-controlled, Double-blind, Dose Escalation Clinical Trial to Evaluate the Safety and Immune Responses of Imcyse's IMCY-0098 in Patients With Recent Onset Type 1 Diabetes

NCT03272269 is registered in ClinicalTrials.gov with Imcyse SA as lead sponsor.

NCT NCT03272269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03272269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Placebo-controlled, Double-blind, Dose Escalation Clinical Trial to Evaluate the Safety and Immune Responses of Imcyse's IMCY-0098 in Patients With Recent Onset Type 1 Diabetes
Lead sponsor
Imcyse SA
Phase
Phase 1
Overall status
Completed
Start date
August 23, 2017
Completion date
August 30, 2019
Enrollment
41 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus